|Name||PRICE||MARKET CAPITALIZATION||PRICE TO EARNINGS RATIO||DIVIDEND YIELD||SYMBOL||EXCHANGE||PRICE PERCENT DIFFERENCE||YEAR TO DATE PRICE PERCENT DIFFERENCE||5 YEAR CHART||1 YEAR CHART|
Esperion Therapeutics Inc [ESPR]
$51.73 0.76 (1.49%)
Market Cap 1.37 Billion
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol. The firm has Business of researching, developing and commercializing therapies for the treatment of patients with the elevated LDL-C operating segment.
EPS 3.26 P/E Ratio 0.00
Previous Earnings Thu, Feb 28, 2019
Pay Date --
This list of trending stocks may change throughout the trading day.